Our Publications

Autoantibody Profiling

Latest Publications


Immuno-Oncology

  • Welberry C, Macdonald I, McElveen J, et al. Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma. PLoS One. 2020;15(5):e0232247. Published 2020 May 6. doi:10.1371/journal.pone.0232247

  • Schulz-Knappe P, Budde P, Zucht H-D, et al. THU0042 Cancer immunotherapy array: a novel screening tool for immune system profiling in cancer immunotherapy bridging autoimmunity and cancer. Ann Rheum Dis 2018;77:247–247. doi:10.1136/annrheumdis-2018-eular.6712

  • Budde P, Marte JL, Zucht H-D et al. THU0043 Autoantibody profiling in prostvac and ipilimumab treated prostate cancer patients reveals potential biomarkers of immune-related adverse events. Annals of the Rheumatic Diseases 2018; 77(Suppl 2):247–247. doi.org/10.1136/annrheumdis-2018-eular.2383

  • Quandt D, Dieter Zucht H, Amann A, Implementing liquid biopsies into clinical decision making for cancer immunotherapy.Oncotarget. 2017 Jul 18;8(29):48507-48520. doi: 10.18632/oncotarget.17397

  • Schlick B, Massoner P, Lueking A, et al. Serum Autoantibodies in Chronic Prostate Inflammation in Prostate Cancer Patients. PloS one 2016;11:e0147739-e. doi.org/10.1371/journal.pone.0147739


Autoimmune Diseases

  • The RA-MAP Consortium. RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients. Sci Data 9, 196 (2022). https://doi.org/10.1038/s41597-022-01264-y

  • Marvin J. Fritzler. Autoantibodies to stratify systemic sclerosis patients into clinically actionable subsets, Autoimmunity Reviews, Volume 19, Issue 8, 2020. https://doi.org/10.1016/j.autrev.2020

  • Teitsma XM, Devenport J, Jacobs JWG, Petho¨-Schramm A, Borm MEA, Budde P, et al. (2020) Comprehensive exploratory autoantibody profiling in patients with early rheumatoid arthritis treated with methotrexate or tocilizumab. PLoS ONE 15(12): e0241189. doi.org/10.1371/ journal.pone.0241189

  • Vordenbäumen S, Brinks R, Schriek P, Lueking A, Richter JG, Budde P, Schulz-Knappe P, Zucht HD, Callhoff J, Schneider M. Profiling of IgG antibodies targeting unmodified and corresponding citrullinated autoantigens in a multicenter national cohort of early arthritis in Germany. Arthritis Res Ther. 2020 Jul 6;22(1):167. doi: 10.1186/s13075-020-02252-6. PMID: 32631453; PMCID: PMC7336616. doi.org/ 10.1186/s13075-020-02252-6

  • Vordenbaumen S, Brinks R, Hoyer A, et al. Comprehensive Longitudinal Surveillance of the IgG Autoantibody Repertoire in Established Systemic Lupus Erythematosus. Arthritis & rheumatology (Hoboken, NJ) 2019;71:736-43. doi.org/doi.org/10.1002/art.40788

  • Bucukovski J, Carter JA, Striemer CC, et al. Label-free microarray-based detection of autoantibodies in human serum. Journal of immunological methods 2018;459:44-9. doi.org/doi.org/10.1016/j.jim.2018.05.011

  • Fritzler MJ, Hudson M, Choi MY, et al. Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype. Autoimmunity Reviews 2018;17:267-75 doi.org/doi.org/10.1016/j.autrev.2018.01.006

  • Cope AP, Barnes MR, Belson A, et al. Erratum: The RA-MAP Consortium: a working model for academia–industry collaboration. Nature Reviews Rheumatology 2018;14:119-. doi.org/doi.org/10.1038/nrrheum.2018.6

  • Vordenbäumen S, Böhmer P, Brinks R, et al. High diagnostic accuracy of histone H4-IgG autoantibodies in systemic lupus erythematosus. Rheumatology 2017;57:533-7. doi.org/doi.org/10.1093/rheumatology/kex462

Infectious Diseases

  • Liu Y., Ebinger JE, Mostafa R., Budde P et al. Paradoxical sex-specific patterns of autoantibody response to SARS-CoV-2 infection. Journal of Translational Medicine (2021) 19:524 doi.org/doi.org/10.1186/s12967-021-03184-8